Swiss National Bank Reduces Stock Position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Swiss National Bank lowered its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 0.5% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 458,441 shares of the real estate investment trust’s stock after selling 2,300 shares during the quarter. Swiss National Bank’s holdings in Sabra Healthcare REIT were worth $8,009,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. State of Michigan Retirement System boosted its position in Sabra Healthcare REIT by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust’s stock valued at $990,000 after buying an additional 600 shares during the period. Louisiana State Employees Retirement System boosted its position in Sabra Healthcare REIT by 0.9% during the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust’s stock valued at $1,158,000 after buying an additional 600 shares during the period. Harbor Capital Advisors Inc. boosted its position in Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust’s stock valued at $76,000 after buying an additional 642 shares during the period. Diversify Advisory Services LLC boosted its position in Sabra Healthcare REIT by 5.7% during the 1st quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust’s stock valued at $226,000 after buying an additional 689 shares during the period. Finally, IFP Advisors Inc boosted its position in Sabra Healthcare REIT by 16.2% during the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust’s stock valued at $88,000 after buying an additional 706 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 0.1%

Shares of Sabra Healthcare REIT stock opened at $18.46 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The company has a 50-day moving average of $18.33 and a 200 day moving average of $17.61. The firm has a market cap of $4.43 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 1.53 and a beta of 0.86. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The company had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. Sabra Healthcare REIT’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $0.36 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.5%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 157.89%.

Wall Street Analyst Weigh In

SBRA has been the subject of several research reports. Scotiabank upped their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a report on Monday, June 23rd. JMP Securities upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a report on Wednesday, August 6th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.00.

Insider Activity

In related news, Director Michael J. Foster sold 11,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the transaction, the director directly owned 64,725 shares in the company, valued at $1,179,289.50. This trade represents a 14.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.20% of the stock is currently owned by insiders.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.